January 2013 Fosamax Federal Court MDL Trial: Scheinberg vs. Merck: ONJ / Jaw Injury Case

This May Be The Final Bellwether Case Trial For IN RE: FOSAMAX PRODUCTS LIABILITY LITIGATION, MDL No. 1789

(Posted by at DrugInjuryWatch.com)

_____________________________________________________________________

UPDATE: This just in: $285,000 plaintiff verdict on failure to warn cause of action.

Merck hit with $285,000 verdict in Fosamax trial  (2/5/13, Reuters)

(2/5/13)

_____________________________________________________________________

The trial of RHODA E. SCHEINBERG, Plaintiff, vs. MERCK & CO., INC., Defendant, Civil Action No.: 1:08-cv-4119, is scheduled to start on January 14, 2013 in the United States District Court for the Southern District of New York ("SDNY")

United States District Court Judge Joseph F. Keenan, who is presiding over IN RE: FOSAMAX PRODUCTS LIABILITY LITIGATION, MDL No. 1789 (SDNY), will be the judge for what may be the final bellwether case trial in this so-called Fosamax – ONJ / Jaw Injury MDL.

Before proceeding, we point out that all pending Fosamax femur fracture cases filed in the federal court system were transferred in May 2011 to the District of New Jersey for coordinated or consolidated pretrial proceedings. This second / separate Fosamax multidistrict litigation (MDL) case is IN RE: FOSAMAX (ALENDRONATE SODIUM) PRODUCTS LIABILITY LITIGATION (NO. II), MDL No. 2243.

As background, in February 2011 Judge Keenan ordered that there will be two additional bellwether trials conducted in this Fosamax MDL. As seen below, on March 28, 2012 Judge Keenan selected Scheinberg v. Merck as the next Fosamax case to be tried and set the trial date for January 14, 2013.

According to the May 1, 2008 Complaint filed for the Scheinberg case, Plaintiff Rhoda Scheinberg "used FOSAMAX from approximately October 25, 2000 through approximately September 2006." The Complaint goes on to allege that:

As a result of the defective nature of FOSAMAX, persons who were prescribed and ingested FOSAMAX, including Plaintiff RHODA E. SCHEINBERG, have suffered and may continue to suffer severe and permanent personal injuries to the jaw bone, including osteonecrosis of the jaw and other diagnoses of irreversible damage to the jaw.

Osteonecrosis of the jaw, often referred to as "ONJ", is a serious medical event and ONJ can result in severe disability for those who develop this painful condition.

_____________________________________________________________________

 

Free Fosamax Case Evaluation 

Strictly Confidential, No Obligation.

______________________________________________________________________________

Notably, the Scheinberg lawsuit is the only federal court Fosamax MDL ONJ case currently set for trial.

Going back to the February 2011 Order by Judge Keenan:

The Court believes it is necessary to conduct two additional bellwether trials involving issues not yet litigated, before considering remand of the MDL to the transferror courts…. One case must involve Fosamax use beginning before the July 2005 label change with a claimed onset of injury after the July 2005 label change. The other case must involve commencement of Fosamax use and a claimed injury date that both post-date the July 2005 label change. [emphasis added]

As indicated above, the Scheinberg trial fits into the first category, with this plaintiff having started her Fosamax use in October 2000.

In a March 29, 2012 Order, however, Judge Keenan later cast some doubt on whether there would be another Fosamax – ONJ trial after the Scheinberg case:

The Court has previously discussed with the parties the Court's belief that at least one additional bellwether trial should be conducted prior to any consideration of a motion to remand to the transferor courts, to address issues arising in cases where the alleged injury date is after the July 2005 change in the Fosamax label….

On March 28, 2012, in open court, Scheinberg v. Merck & Co., Inc., No. 08 Civ. 4119 (JFK) , was first selected by lot…. [emphasis added]

We expect, based on earlier Fosamax – ONJ trials, that it will be at least a month before we will get a jury verdict for the Scheinberg v. Merck trial.

Of course, to the extent that we get reports of significant developments along the way, we will let you know, here.

______________________________________________________________________________

DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects  (All website content by attorney Tom Lamb)

Drug Injury Case Evaluation – Free & Confidential  (Review done by attorney Tom Lamb)

2 responses to “January 2013 Fosamax Federal Court MDL Trial: Scheinberg vs. Merck: ONJ / Jaw Injury Case”

  1. fbstapleton@cox.net Avatar
    fbstapleton@cox.net

    I begged to have a Bone Density procedure because both sister and mother had osteoporosis. However, because I had been on hormones, exercised, etc. it was thought the possibilities were for me were minor. Now at 86 yo I am active and with no observed bone problems at this time. In my opinion Fosamax was started with me about the time it came to the market. I was on it for at least ten years. My family pressured me to discontinue it because of the negative publicity. I tell you this because in my opinion many of us have been helped with Fosamax. There are always the exceptions to any rule, product etc. Just one of the many who stand up and cheer Fosama!

  2. Bonnie Avatar
    Bonnie

    I have had both ONJ, atypical spontaneous femur fractures x2 plus bilateral foot fractures as a result of 84 month use of iv AREDIA & ZOMETA. I tell you this because prior to my use of these drugs I had never had a bone fracture. Given the drugs iv, I was told they woul stop the diagnosis of metastatic breast to my bones from eating up my bones. I took these drugs from 2000-2007. My first atypical femur fracture occurred on December 17, 2006.

Leave a Reply

Your email address will not be published. Required fields are marked *